SCHEDULE: Charles Schwab Investment Management Discloses 5.41% Stake in Medifast
Beneficial Ownership Report (Schedule 13G)
Charles Schwab Investment Management Inc. has reported a 5.41% passive ownership stake in Medifast Inc. common stock.
Summary
- Charles Schwab Investment Management Inc. (CSIM) filed a Schedule 13G, indicating beneficial ownership in Medifast Inc.
- CSIM beneficially owns 595,211 shares of Medifast Inc. Common Stock.
- This ownership represents 5.41% of Medifast Inc.'s class of securities.
- CSIM holds sole voting power and sole dispositive power over all 595,211 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Medifast Inc.
Sentiment
Score: 6
Explanation: The filing is a factual disclosure of a significant passive ownership stake by a major investment manager, which can be interpreted as a positive signal of confidence in the issuer, though it contains no performance data.
Positives
- Charles Schwab Investment Management Inc., a major institutional investor, has taken a significant passive stake in Medifast Inc., which can be interpreted as a signal of confidence in the company.
Future Outlook
NA
Industry Context
This filing is a standard disclosure for institutional investors who acquire more than 5% of a company's outstanding shares, indicating a passive investment position. It reflects an investment decision by a large asset manager, Charles Schwab Investment Management, regarding Medifast Inc.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by Charles Schwab Investment Management Inc. may instill greater confidence and potentially contribute to market stability for Medifast Inc. shares.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring the filing of this statement |
| 11/11/2025 | Date of signature by Omar Aguilar, Chief Executive Officer of Charles Schwab Investment Management Inc. |
Recommendation
holdThe Schedule 13G filing indicates a significant passive ownership stake by Charles Schwab Investment Management Inc. in Medifast Inc. While this signals institutional confidence, the filing itself does not provide financial performance data or strategic updates to warrant a 'buy' or 'sell' recommendation. Investors should consider this information as a data point within a broader analysis of Medifast's fundamentals and market conditions.
Keywords
Medifast, Charles Schwab Investment Management, 13G, Common Stock, Beneficial Ownership, Passive Investment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.